HEART UK responds to Dept of Health announcement on new cholesterol drug
The cholesterol charity HEART UK responds to the Department of Health and Social Care announcement that a new cholesterol drug, inclisiran, could be made available for NHS patients through a ground-breaking collaboration.
Jules Payne, Chief Executive of the cholesterol charity HEART UK, said: “Cholesterol is a leading cause of heart disease, so effective treatments save lives.
“While we know beyond doubt that statins are incredibly effective at treating people with high cholesterol, there is a desperate need for new and innovative drugs if we are to tackle cardiovascular disease, a condition which kills hundreds of thousands of people in this country every year.
“The potential for this breakthrough new drug is incredibly exciting but we need to ensure all those eligible for it, once fully approved, will get access to it.”
For more information and interviews, please contact the HEART UK media team on 07736 469509 or email firstname.lastname@example.org
- New child screening service to identify youngsters at risk of early heart disease
- HEART UK partners with Loch Duart
- Jules Payne, CEO, talks about how HEART UK will shape the future for people with high cholesterol
- Wishing you a Heart-healthy Ramadan!
- Having FH should not stop you joining the armed forces- thanks to the work of HEART UK
- How to have a heart healthy Veganuary and enter a free prize draw
- FH is a global health problem- FH Awareness Day 24th September
- Dr Pete Green is the new Chair of HEART UK
- UK NATIONAL SCREENING COMMITTEE REJECTS CALLS FOR UNIVERSAL CHILDHOOD SCREENING FOR INHERITIED HIGH CHOLESTEROL
- Emergency heart attack and stroke centres are still here for you- Jules Payne interviews Dr Ricardo Petraco